Snowy Owl
Retired in 2010, In Memoriam
Hospital bloc plans for pandemic
Thu, June 1, 2006
Thu, June 1, 2006
Hospitals decide protecting staff beats waiting for outbreak.
By HELEN BRANSWELL, CP
http://lfpress.ca/newsstand/CityandRegion/2006/06/01/1609190-sun.html
By HELEN BRANSWELL, CP
http://lfpress.ca/newsstand/CityandRegion/2006/06/01/1609190-sun.html
TORONTO -- A bloc of Canada's largest and most influential teaching hospitals has decided to buy enough of the antiviral drug Tamiflu to protect all of their employees from becoming ill during a pandemic -- a decision that will require huge and costly reserves of the drug.
The policy runs counter to the current federal, provincial and territorial thinking, which suggests saving limited stores of Tamiflu for the treatment of people who become sick rather than trying to stave off illness, a drug-intensive process called prophylaxis.
The move could place significant pressure on other hospitals and public health officials to follow suit; health-care unions elsewhere could demand the same level of protection in exchange for assurances their members will show up for work during a pandemic.
"I think there's really no reason why unions wouldn't say 'This is what we want' following that example," Dr. Perry Kendall, chief medical officer of health for British Columbia said of the announcement from the Toronto Academic Health Services Network, which comprises 12 hospitals, including the Hospital for Sick Children and St. Michael's Hospital.
Kendall and others suggested the decision reflects the high level of trauma that haunts health-care workers in Toronto as a result of the city's devastating SARS outbreak in the spring of 2003. That disease spread largely in hospitals and it took an extraordinary toll on health-care workers and their families.
The committee that took the decision to use Tamiflu to protect all staff countered that SARS did play a role, but not the role their critics contend. The decision was not fuelled by post-traumatic stress, they argued, but by the understanding that the only way to keep hospitals functioning during a pandemic will be to stop staff from getting sick.
"It was sufficiently clear to us that this was the best thing to do for our hospitals and for the patients we need to be taking care of; that what other people were going to think about it (the decision) or what external implications it was going to have just wasn't relevant," said Dr. Allison McGeer, head of infection control at Toronto's Mount Sinai Hospital.
"This is not a decision that was taken on an emotional basis . . . This was a decision that was taken on cold, hard facts."
The decision involves buying enough drug to protect 55,000 employees for 56 days -- the rough estimate of what it might take for the first wave of a pandemic to move through the community. (The belief is Canada's pandemic vaccine manufacturer, GlaxoSmithKline, will have vaccine ready in time to protect against a second wave of illness.)
That's more than three million Tamiflu pills, at a cost of $7.2 million dollars.
The policy runs counter to the current federal, provincial and territorial thinking, which suggests saving limited stores of Tamiflu for the treatment of people who become sick rather than trying to stave off illness, a drug-intensive process called prophylaxis.
The move could place significant pressure on other hospitals and public health officials to follow suit; health-care unions elsewhere could demand the same level of protection in exchange for assurances their members will show up for work during a pandemic.
"I think there's really no reason why unions wouldn't say 'This is what we want' following that example," Dr. Perry Kendall, chief medical officer of health for British Columbia said of the announcement from the Toronto Academic Health Services Network, which comprises 12 hospitals, including the Hospital for Sick Children and St. Michael's Hospital.
Kendall and others suggested the decision reflects the high level of trauma that haunts health-care workers in Toronto as a result of the city's devastating SARS outbreak in the spring of 2003. That disease spread largely in hospitals and it took an extraordinary toll on health-care workers and their families.
The committee that took the decision to use Tamiflu to protect all staff countered that SARS did play a role, but not the role their critics contend. The decision was not fuelled by post-traumatic stress, they argued, but by the understanding that the only way to keep hospitals functioning during a pandemic will be to stop staff from getting sick.
"It was sufficiently clear to us that this was the best thing to do for our hospitals and for the patients we need to be taking care of; that what other people were going to think about it (the decision) or what external implications it was going to have just wasn't relevant," said Dr. Allison McGeer, head of infection control at Toronto's Mount Sinai Hospital.
"This is not a decision that was taken on an emotional basis . . . This was a decision that was taken on cold, hard facts."
The decision involves buying enough drug to protect 55,000 employees for 56 days -- the rough estimate of what it might take for the first wave of a pandemic to move through the community. (The belief is Canada's pandemic vaccine manufacturer, GlaxoSmithKline, will have vaccine ready in time to protect against a second wave of illness.)
That's more than three million Tamiflu pills, at a cost of $7.2 million dollars.